开放期刊系统

持续与间歇β内酰胺类抗生素输注治疗重症脓毒症患者的临床研究

张 秋玲

摘要

目的了解持续与间歇β内酰胺类抗生素输注治疗重症脓毒症患者的临床效果。方法筛选我院82例的重症脓毒症病患,对应时间段为2024年1月-12月,分为两组,全部接受美罗培南治疗,其中对照组为间歇输注,而研究组为持续输注。结果研究组治疗效果更高(P<0.05);研究组预后情况更好(P<0.05);研究组炎性因子水平更符合正常值(P<0.05)。结论对重症脓毒症施以β内酰胺类抗生素持续输注的效果理想,可以有效提高临床治愈率,控制28d死亡率,改善APACHEⅡ评分,消除炎性反应,应该推广。

关键词

持续输注;间歇输注;β内酰胺类抗生素;美罗培南;重症脓毒症;临床效果

全文:

PDF


参考

[1]刘倩,王肖肖,闫文文,等.重症脓毒症患者血清 HBP 和 Presepsin 水平对其急性肾损伤的预测[J].标记免疫分析与临床,2024,31(7):1298-1302.

[1]周心怡,胡琳,傅孟元,等.β内酰胺类抗生素过敏去标签措施及其效果的范围综述[J].中华临床免疫和变态反应杂志,2024,18(6):519-528.

[3]Veling L S,Van Wolffelaar F F,Tjomme V D B,et al.Paediatric cancer patients with severe sepsis or septic shock at the PICU with positive microbiological results do worse than those with negative results:a retrospective cohort study[J].Intensive Care Medicine - Paediatric & Neonatal,2024,2(1):23-25.

[4]李东风,李雅琳,孙振康,等.延长美罗培南输注时间对老年脓毒症患者预后的影响[J].实用临床医药杂志,2023,27(15):115-119.

[5]Bertolotto M,Verzola D,Contini P,et al.Osteopontin is associated with neutrophil extracellular trap formation in elderly patients with severe sepsis[J].European Journal of Clinical Investigation,2024,54(4):57-59.

[6]刘旸,陈加链,林谦,等.美罗培南不同输注方式治疗脓毒症的疗效和安全性比较[J].临床合理用药杂志,2023,16(32):47-50.

[7]尹小君,李大欢,张冲,等.美罗培南对脓毒症休克患者血清 H-FABP 和 I-FABP 及 Gal-3 水平的影响[J].热带医学杂志,2023,22(9):1261-1265.

[8]Allam M G I M.Effect of Bronchoscopy on the Outcome of Patients with Severe Sepsis,Acute Respiratory Distress Syndrome and Complicated by Ventilator Associated Pneumonia from Prolonged Ventilation[J].The Open Anesthesia Journal,2023,17(1):1-13.

[9]成人脓毒症患者β-内酰胺类抗生素延长输注专家共识编写组.成人脓毒症患者β-内酰胺类抗生素延长输注专家共识[J].中华重症医学电子杂志,2024,10(4):313-324.

[10]Malinverni S,Ochogavia Q,Lecrenier S,et al.Severe vitamin D deficiency in patients admitted to the emergency department with severe sepsis is associated with an increased 90-day mortality[J].Emergency medicine journal:EMJ,2023,40(1):36-41.

[11]韩玉,阮培森,郑耀,等.美罗培南不同输注模式对儿童严重脓毒症的疗效观察[J].中国现代医生,2024,25(29):18-20.


(0 摘要 Views, 0 PDF Downloads)

Refbacks

  • 当前没有refback。